Tapewire

NYSE · USD

ZTS

Zoetis Inc.

Export transactions ↓
Tapewire entity
679
SEC CIK
0001555280
Parsed reports
1,182

Last 12 months

Inside the activity.

3 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202602
Mar 202600
Apr 202600
May 202630
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 01, 2020 Filed May 4, 2020 20:49 UTC
Chen Heidi C.Executive Vice President
SaleCommon Stock 1,179 $127.44 $150,251.76
Disclosure

SEC source: 0001555280-20-000192 · wf-form4_158862533753154.xml · nonDerivative · entry 2

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,335

Read SEC document
May 01, 2020 Filed May 4, 2020 20:49 UTC
Chen Heidi C.Executive Vice President
Exercise / conversionCommon Stock 1,179 $41.83 $49,317.57
Disclosure

SEC source: 0001555280-20-000192 · wf-form4_158862533753154.xml · nonDerivative · entry 1

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,514

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019.

Read SEC document
April 29, 2020 Filed Sep 15, 2020 16:25 UTC GiftCommon Stock 5,620 $0.00 $0.00
Disclosure

SEC source: 0001555280-20-000278 · wf-form4_160020154200980.xml · nonDerivative · entry 1

Norden Gregory · CIK 0001405104 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,164

Read SEC document
April 15, 2020 Filed Apr 17, 2020 21:04 UTC
PECK KRISTIN CDirector · Chief Executive Officer
GrantPhantom Stock Unit · Derivative 839.1061 $38.93 $32,666.40
Disclosure

SEC source: 0001555280-20-000181 · wf-form4_158715745685962.xml · derivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,716.9605

Underlying: Common Stock · 263.843 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
April 15, 2020 Filed Apr 17, 2020 21:12 UTC
Kelly Robert EdwardExecutive Vice President
GrantPhantom Stock Unit · Derivative 160.5479 $38.93 $6,250.13
Disclosure

SEC source: 0001555280-20-000184 · wf-form4_158715793941248.xml · derivative · entry 1

Kelly Robert Edward · CIK 0001798683 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,957.585

Underlying: Common Stock · 50.4816 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
April 15, 2020 Filed Apr 17, 2020 21:21 UTC
Bettington Timothy JExecutive Vice President
GrantPhantom Stock Unit · Derivative 103.737 $38.93 $4,038.48
Disclosure

SEC source: 0001555280-20-000188 · wf-form4_158715847267264.xml · derivative · entry 1

Bettington Timothy J · CIK 0001797894 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103.737

Underlying: Common Stock · 32.6184 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
April 15, 2020 Filed Apr 17, 2020 21:19 UTC
Knupp Catherine A.Executive Vice President
GrantPhantom Stock Unit · Derivative 736.9997 $38.93 $28,691.40
Disclosure

SEC source: 0001555280-20-000187 · wf-form4_158715833909249.xml · derivative · entry 1

Knupp Catherine A. · CIK 0001567826 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,056.662

Underlying: Common Stock · 231.7373 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
April 15, 2020 Filed Apr 17, 2020 21:17 UTC
Mamilli WafaaExecutive Vice President
GrantPhantom Stock Unit · Derivative 1,340.177 $38.93 $52,173.09
Disclosure

SEC source: 0001555280-20-000186 · wf-form4_158715821906265.xml · derivative · entry 1

Mamilli Wafaa · CIK 0001800960 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,340.177

Underlying: Common Stock · 421.3964 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
April 15, 2020 Filed Apr 17, 2020 21:15 UTC
Chen Heidi C.Executive Vice President
GrantPhantom Stock Unit · Derivative 479.7372 $38.93 $18,676.17
Disclosure

SEC source: 0001555280-20-000185 · wf-form4_158715808632907.xml · derivative · entry 1

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,177.5524

Underlying: Common Stock · 150.8454 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
April 15, 2020 Filed Apr 17, 2020 21:09 UTC GrantPhantom Stock Unit · Derivative 2,393.9422 $38.93 $93,196.17
Disclosure

SEC source: 0001555280-20-000183 · wf-form4_158715776439399.xml · derivative · entry 1

Alaix Juan Ramon · CIK 0001567824 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,022.4609

Underlying: Common Stock · 752.7354 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
April 15, 2020 Filed Apr 17, 2020 21:07 UTC
David GlennChief Financial Officer
GrantPhantom Stock Unit · Derivative 740.9268 $38.93 $28,844.28
Disclosure

SEC source: 0001555280-20-000182 · wf-form4_158715760462903.xml · derivative · entry 1

David Glenn · CIK 0001606256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,841.2411

Underlying: Common Stock · 232.9721 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
April 15, 2020 Filed Apr 17, 2020 21:02 UTC
Lagano RoxanneExecutive Vice President
GrantPhantom Stock Unit · Derivative 404.0984 $38.93 $15,731.55
Disclosure

SEC source: 0001555280-20-000180 · wf-form4_158715732317398.xml · derivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,435.106

Underlying: Common Stock · 127.062 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
April 07, 2020 Filed Apr 7, 2020 20:24 UTC
Trawicki RomanExecutive Vice President
Exercise / conversionStock Option · Derivative 4,079 $0.00 $0.00
Disclosure

SEC source: 0001555280-20-000170 · wf-form4_158629108231547.xml · derivative · entry 3

Trawicki Roman · CIK 0001640777 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,656

Underlying: Common Stock · 4,079 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F4 · derivative.exercise_price: 4,079 options granted February 14, 2017 at an exercise price of $55.02 per option.

F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 8,159 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,142 options granted February 13, 2018 at an exercise price of $73.24 per option; 13,774 options granted February 12, 2019 at an exercise price of $87.51 per option; and 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option.

Read SEC document
April 07, 2020 Filed Apr 7, 2020 20:24 UTC
Trawicki RomanExecutive Vice President
SaleCommon Stock 5,499 $130.00 $714,870.00
Disclosure

SEC source: 0001555280-20-000170 · wf-form4_158629108231547.xml · nonDerivative · entry 2

Trawicki Roman · CIK 0001640777 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,841

F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions.

Read SEC document
April 07, 2020 Filed Apr 7, 2020 20:24 UTC
Trawicki RomanExecutive Vice President
Exercise / conversionCommon Stock 4,079 $55.02 $224,426.58
Disclosure

SEC source: 0001555280-20-000170 · wf-form4_158629108231547.xml · nonDerivative · entry 1

Trawicki Roman · CIK 0001640777 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,340

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2019.

Read SEC document
April 06, 2020 Filed Apr 7, 2020 20:21 UTC
Chen Heidi C.Executive Vice President
Exercise / conversionStock Option · Derivative 1,179 $0.00 $0.00
Disclosure

SEC source: 0001555280-20-000169 · wf-form4_158629087123021.xml · derivative · entry 3

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,302

Underlying: Common Stock · 1,179 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Stock option (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F3 · derivative.exercise_price: 1,179 options granted February 19, 2016 at an exercise price of $41.83 per option.

F4 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F5 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F6 · balance_after: 9,433 options granted February 19, 2016 at an exercise price of $41.83 per option; 24,475 options granted February 14, 2017 at an exercise price of $55.02 per option; 18,892 options granted February 13, 2018 at an exercise price of $73.24 per option; 14,921 options granted February 12, 2019 at an exercise price of $87.51 per option; and 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option.

Read SEC document
April 06, 2020 Filed Apr 7, 2020 20:21 UTC
Chen Heidi C.Executive Vice President
SaleCommon Stock 1,179 $120.00 $141,480.00
Disclosure

SEC source: 0001555280-20-000169 · wf-form4_158629087123021.xml · nonDerivative · entry 2

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,335

Read SEC document
April 06, 2020 Filed Apr 7, 2020 20:21 UTC
Chen Heidi C.Executive Vice President
Exercise / conversionCommon Stock 1,179 $41.83 $49,317.57
Disclosure

SEC source: 0001555280-20-000169 · wf-form4_158629087123021.xml · nonDerivative · entry 1

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,514

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019.

Read SEC document
March 31, 2020 Filed Apr 2, 2020 16:18 UTC
Pudloski Sherry NExecutive Vice President
GrantStock Option · Derivative 8,048 $0.00 $0.00
Disclosure

SEC source: 0001555280-20-000148 · wf-form4_158585868418960.xml · derivative · entry 2

Pudloski Sherry N · CIK 0001806929 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,048

Underlying: Common Stock · 8,048 shares

Expires not disclosed

F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F7 · derivative.exercise_price: 8,048 options granted March 31, 2020 at an exercise price of $117.69 per option.

F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 8,048 options granted March 31, 2020 at an exercise price of $117.69 per option.

Read SEC document
March 31, 2020 Filed Apr 2, 2020 16:18 UTC
Pudloski Sherry NExecutive Vice President
GrantRestricted Stock Unit · Derivative 2,124 $0.00 $0.00
Disclosure

SEC source: 0001555280-20-000148 · wf-form4_158585868418960.xml · derivative · entry 1

Pudloski Sherry N · CIK 0001806929 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,124

Underlying: Common Stock · 2,124 shares

Expires not disclosed

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

F5 · balance_after: The RSUs vest as follows: 2,124 RSUs will vest on March 31, 2023.

Read SEC document
March 31, 2020 Filed Apr 2, 2020 23:06 UTC
PECK KRISTIN CDirector · Chief Executive Officer
GrantPhantom Stock Unit · Derivative 1,543.0995 $37.07 $57,202.70
Disclosure

SEC source: 0001555280-20-000158 · wf-form4_158586874573869.xml · derivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,877.8544

Underlying: Common Stock · 486.0455 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
March 31, 2020 Filed Apr 2, 2020 23:04 UTC
Lagano RoxanneExecutive Vice President
GrantPhantom Stock Unit · Derivative 1,006.5754 $37.07 $37,313.75
Disclosure

SEC source: 0001555280-20-000157 · wf-form4_158586863608669.xml · derivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,031.0076

Underlying: Common Stock · 317.0512 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
March 31, 2020 Filed Apr 2, 2020 23:22 UTC
McFarland James MichaelExecutive Vice President
GrantPhantom Stock Unit · Derivative 306.1732 $37.07 $11,349.84
Disclosure

SEC source: 0001555280-20-000166 · wf-form4_158586971966618.xml · derivative · entry 1

McFarland James Michael · CIK 0001801162 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,310.3883

Underlying: Common Stock · 96.4384 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
March 31, 2020 Filed Apr 2, 2020 23:17 UTC
Nayak Abhay USenior Vice President
GrantPhantom Stock Unit · Derivative 224.0688 $37.07 $8,306.23
Disclosure

SEC source: 0001555280-20-000163 · wf-form4_158586944738247.xml · derivative · entry 1

Nayak Abhay U · CIK 0001797754 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 294.8212

Underlying: Common Stock · 70.5772 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
March 31, 2020 Filed Apr 2, 2020 23:19 UTC
Knupp Catherine A.Executive Vice President
GrantPhantom Stock Unit · Derivative 1,463.2843 $37.07 $54,243.95
Disclosure

SEC source: 0001555280-20-000164 · wf-form4_158586954436754.xml · derivative · entry 1

Knupp Catherine A. · CIK 0001567826 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,319.6623

Underlying: Common Stock · 460.9053 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
March 31, 2020 Filed Apr 2, 2020 23:15 UTC
Chen Heidi C.Executive Vice President
GrantPhantom Stock Unit · Derivative 1,142.7027 $37.07 $42,359.99
Disclosure

SEC source: 0001555280-20-000162 · wf-form4_158586934193850.xml · derivative · entry 1

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,697.8152

Underlying: Common Stock · 359.9285 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
March 31, 2020 Filed Apr 2, 2020 23:14 UTC
Kelly Robert EdwardExecutive Vice President
GrantPhantom Stock Unit · Derivative 798.6623 $37.07 $29,606.41
Disclosure

SEC source: 0001555280-20-000161 · wf-form4_158586922800393.xml · derivative · entry 1

Kelly Robert Edward · CIK 0001798683 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,797.0371

Underlying: Common Stock · 251.5627 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
March 31, 2020 Filed Apr 2, 2020 23:11 UTC GrantPhantom Stock Unit · Derivative 4,353.2509 $37.07 $161,375.01
Disclosure

SEC source: 0001555280-20-000160 · wf-form4_158586906620664.xml · derivative · entry 1

Alaix Juan Ramon · CIK 0001567824 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,628.5187

Underlying: Common Stock · 1,371.1871 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
March 31, 2020 Filed Apr 2, 2020 23:09 UTC
David GlennChief Financial Officer
GrantPhantom Stock Unit · Derivative 1,483.5568 $37.07 $54,995.45
Disclosure

SEC source: 0001555280-20-000159 · wf-form4_158586895581518.xml · derivative · entry 1

David Glenn · CIK 0001606256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,100.3143

Underlying: Common Stock · 467.2908 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
March 23, 2020 Filed Mar 25, 2020 16:20 UTC GrantPhantom Stock Unit · Derivative 269.8036 $92.66 $25,000.00
Disclosure

SEC source: 0001555280-20-000146 · wf-form4_158516758544921.xml · derivative · entry 1

STEERE WILLIAM C JR · CIK 0001033870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,853.5638

Underlying: Common Stock · 269.8036 shares

Expires not disclosed

F1 · security: These phantom stock units were acquired pursuant to the Zoetis Non-Employee Director Deferred Compensation Plan and represent the director's deferral of all or a portion of his or her cash retainer fees invested in the Zoetis stock fund (including dividend equivalents thereon).

F2 · derivative.exercise_price: Each phantom stock unit represents one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: These phantom stock units will be settled in cash following the reporting person's separation from service.

F3 · derivative.expiration_date: These phantom stock units will be settled in cash following the reporting person's separation from service.

Read SEC document
March 05, 2020 Filed Mar 6, 2020 22:19 UTC
David GlennChief Financial Officer
Exercise / conversionStock Option · Derivative 32,634 $0.00 $0.00
Disclosure

SEC source: 0001555280-20-000142 · wf-form4_158353318091537.xml · derivative · entry 6

David Glenn · CIK 0001606256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,469

Underlying: Common Stock · 32,634 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F8 · derivative.exercise_price: 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option.

F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F9 · balance_after: 7,712 options granted February 27, 2015 at an exercise price of $46.09 per option; 26,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 24,678 options granted February 12, 2019 at an exercise price of $87.51 per option; and 18,794 options granted February 11, 2020 at an exercise price of $144.03 per option.

Read SEC document
March 05, 2020 Filed Mar 6, 2020 22:19 UTC
David GlennChief Financial Officer
Exercise / conversionStock Option · Derivative 11,144 $0.00 $0.00
Disclosure

SEC source: 0001555280-20-000142 · wf-form4_158353318091537.xml · derivative · entry 5

David Glenn · CIK 0001606256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,103

Underlying: Common Stock · 11,144 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F4 · derivative.exercise_price: 11,144 options granted December 6, 2016 at an exercise price of $50.22 per option.

F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 7,712 options granted February 27, 2015 at an exercise price of $46.09 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 26,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 24,678 options granted February 12, 2019 at an exercise price of $87.51 per option; and 18,794 options granted February 11, 2020 at an exercise price of $144.03 per option.

Read SEC document
March 05, 2020 Filed Mar 6, 2020 22:19 UTC
David GlennChief Financial Officer
SaleCommon Stock 7,940 $141.24 $1,121,445.60
Disclosure

SEC source: 0001555280-20-000142 · wf-form4_158353318091537.xml · nonDerivative · entry 4

David Glenn · CIK 0001606256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,741

F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.12 to $141.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 05, 2020 Filed Mar 6, 2020 22:19 UTC
David GlennChief Financial Officer
SaleCommon Stock 35,838 $140.81 $5,046,348.78
Disclosure

SEC source: 0001555280-20-000142 · wf-form4_158353318091537.xml · nonDerivative · entry 3

David Glenn · CIK 0001606256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,681

F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.11 to $141.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 05, 2020 Filed Mar 6, 2020 22:19 UTC
David GlennChief Financial Officer
Exercise / conversionCommon Stock 32,634 $55.02 $1,795,522.68
Disclosure

SEC source: 0001555280-20-000142 · wf-form4_158353318091537.xml · nonDerivative · entry 2

David Glenn · CIK 0001606256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,519

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 05, 2020 Filed Mar 6, 2020 22:19 UTC
David GlennChief Financial Officer
Exercise / conversionCommon Stock 11,144 $50.22 $559,651.68
Disclosure

SEC source: 0001555280-20-000142 · wf-form4_158353318091537.xml · nonDerivative · entry 1

David Glenn · CIK 0001606256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,885

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 04, 2020 Filed Mar 5, 2020 21:26 UTC Exercise / conversionStock Option · Derivative 170,163 $0.00 $0.00
Disclosure

SEC source: 0001555280-20-000140 · wf-form4_158344355335410.xml · derivative · entry 12

Alaix Juan Ramon · CIK 0001567824 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 243,262

Underlying: Common Stock · 170,163 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F13 · derivative.exercise_price: 170,163 options granted February 14, 2017 at an exercise price of $55.02 per option.

F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F14 · balance_after: 133,070 options granted February 13, 2018 at an exercise price of $73.24 per option; and 110,192 options granted February 12, 2019 at an exercise price of $87.51 per option.

Read SEC document
March 04, 2020 Filed Mar 5, 2020 21:26 UTC Exercise / conversionStock Option · Derivative 48,045 $0.00 $0.00
Disclosure

SEC source: 0001555280-20-000140 · wf-form4_158344355335410.xml · derivative · entry 11

Alaix Juan Ramon · CIK 0001567824 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 413,425

Underlying: Common Stock · 48,045 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F11 · derivative.exercise_price: 48,045 options granted February 19, 2016 at an exercise price of $41.83 per option.

F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F12 · balance_after: 170,163 options granted February 14, 2017 at an exercise price of $55.02 per option; 133,070 options granted February 13, 2018 at an exercise price of $73.24 per option; and 110,192 options granted February 12, 2019 at an exercise price of $87.51 per option.

Read SEC document
March 04, 2020 Filed Mar 5, 2020 21:26 UTC SaleCommon Stock 7,499 $143.13 $1,073,331.87
Disclosure

SEC source: 0001555280-20-000140 · wf-form4_158344355335410.xml · nonDerivative · entry 9

Alaix Juan Ramon · CIK 0001567824 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,013

F5 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.03 to $143.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 04, 2020 Filed Mar 5, 2020 21:26 UTC SaleCommon Stock 48,487 $142.40 $6,904,548.80
Disclosure

SEC source: 0001555280-20-000140 · wf-form4_158344355335410.xml · nonDerivative · entry 8

Alaix Juan Ramon · CIK 0001567824 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,512

F4 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.02 to $143.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 04, 2020 Filed Mar 5, 2020 21:26 UTC SaleCommon Stock 78,738 $141.33 $11,128,041.54
Disclosure

SEC source: 0001555280-20-000140 · wf-form4_158344355335410.xml · nonDerivative · entry 7

Alaix Juan Ramon · CIK 0001567824 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,999

F3 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.01 to $142.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 04, 2020 Filed Mar 5, 2020 21:26 UTC SaleCommon Stock 83,484 $140.68 $11,744,529.12
Disclosure

SEC source: 0001555280-20-000140 · wf-form4_158344355335410.xml · nonDerivative · entry 6

Alaix Juan Ramon · CIK 0001567824 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 230,737

F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.00 to $141.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 04, 2020 Filed Mar 5, 2020 21:26 UTC Exercise / conversionCommon Stock 170,163 $55.02 $9,362,368.26
Disclosure

SEC source: 0001555280-20-000140 · wf-form4_158344355335410.xml · nonDerivative · entry 5

Alaix Juan Ramon · CIK 0001567824 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 314,221

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 04, 2020 Filed Mar 5, 2020 21:26 UTC Exercise / conversionCommon Stock 48,045 $41.83 $2,009,722.35
Disclosure

SEC source: 0001555280-20-000140 · wf-form4_158344355335410.xml · nonDerivative · entry 4

Alaix Juan Ramon · CIK 0001567824 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 144,058

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 03, 2020 Filed Mar 5, 2020 21:26 UTC Exercise / conversionStock Option · Derivative 45,452 $0.00 $0.00
Disclosure

SEC source: 0001555280-20-000140 · wf-form4_158344355335410.xml · derivative · entry 10

Alaix Juan Ramon · CIK 0001567824 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 461,470

Underlying: Common Stock · 45,452 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F7 · derivative.exercise_price: 45,452 options granted February 19, 2016 at an exercise price of $41.83 per option.

F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F10 · balance_after: 48,045 options granted February 19, 2016 at an exercise price of $41.83 per option; 170,163 options granted February 14, 2017 at an exercise price of $55.02 per option; 133,070 options granted February 13, 2018 at an exercise price of $73.24 per option; and 110,192 options granted February 12, 2019 at an exercise price of $87.51 per option.

Read SEC document
March 03, 2020 Filed Mar 5, 2020 21:26 UTC SaleCommon Stock 13,930 $141.21 $1,967,055.30
Disclosure

SEC source: 0001555280-20-000140 · wf-form4_158344355335410.xml · nonDerivative · entry 3

Alaix Juan Ramon · CIK 0001567824 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,013

F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.01 to $141.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 03, 2020 Filed Mar 5, 2020 21:26 UTC SaleCommon Stock 31,522 $140.41 $4,426,004.02
Disclosure

SEC source: 0001555280-20-000140 · wf-form4_158344355335410.xml · nonDerivative · entry 2

Alaix Juan Ramon · CIK 0001567824 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,943

F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.00 to $141.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 03, 2020 Filed Mar 5, 2020 21:26 UTC Exercise / conversionCommon Stock 45,452 $41.83 $1,901,257.16
Disclosure

SEC source: 0001555280-20-000140 · wf-form4_158344355335410.xml · nonDerivative · entry 1

Alaix Juan Ramon · CIK 0001567824 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 141,465

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 02, 2020 Filed Mar 3, 2020 21:35 UTC
Chen Heidi C.Executive Vice President
Exercise / conversionStock Option · Derivative 1,179 $0.00 $0.00
Disclosure

SEC source: 0001555280-20-000138 · wf-form4_158327133475310.xml · derivative · entry 3

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,481

Underlying: Common Stock · 1,179 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock option (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F4 · derivative.exercise_price: 1,179 options granted February 19, 2016 at an exercise price of $41.83 per option.

F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 10,612 options granted February 19, 2016 at an exercise price of $41.83 per option; 24,475 options granted February 14, 2017 at an exercise price of $55.02 per option; 18,892 options granted February 13, 2018 at an exercise price of $73.24 per option; 14,921 options granted February 12, 2019 at an exercise price of $87.51 per option; and 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option.

Read SEC document
March 02, 2020 Filed Mar 3, 2020 21:35 UTC
Chen Heidi C.Executive Vice President
SaleCommon Stock 1,179 $134.30 $158,339.70
Disclosure

SEC source: 0001555280-20-000138 · wf-form4_158327133475310.xml · nonDerivative · entry 2

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,335

F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.